Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Durand

Showing results (21-30 of 220) with videos related to

Pageof 22
Sort By:
Lancet (London, England)|March 12, 1999
Parvovirus B19 infection and fulminant hepatitisJ Bernuau, F Durand, D Valla
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|January 1, 1995
[Development of a control method for sample distributors]F Durand, B Annic, B Genetet
Annals of Internal Medicine|July 6, 2000
Evidence of hepatitis C virus viremia without detectable antibody to hepatitis C virus in a blood donorF Durand, A Beauplet, P Marcellin
Medicine and Science in Sports and Exercise|May 5, 2000
Evidence for an inadequate hyperventilation inducing arterial hypoxemia at submaximal exercise in all highly trained endurance athletesF Durand, P Mucci, C Préfaut
Gastroenterologie Clinique Et Biologique|July 11, 2008
[Refractory ascites in patients with cirrhosis]R Moreau, F Durand, D Lebrec
Hepatology (Baltimore, Md.)|September 26, 1997
Ketoconazole-induced hepatotoxicityJ Bernuau, F Durand, D Pessayre
Acta Endocrinologica|September 1, 1978
Effect of glucocorticoids on plasma testosterone in menG Schaison, F Durand, I Mowszowicz
Journal of Chromatography|December 18, 1981
A fast and simple high-performance liquid chromatographic assay for aryl hydrocarbon hydroxylaseJ E Tulliez, E F Durand
Gastroenterologie Clinique Et Biologique|March 28, 2008
[Nutritional assessment in cirrhosis]S Buyse, F Durand, F Joly
Gastroenterologie Clinique Et Biologique|October 8, 1998
[Hepatotoxicity of antituberculosis drugs: practical implications for monitoring]F Durand, J Bernuau, D Pessayre
Pageof 22

Showing results (21-30 of 220) with videos related to

Sort By:
Pageof 22
Lancet (London, England)|March 12, 1999
Parvovirus B19 infection and fulminant hepatitisJ Bernuau, F Durand, D Valla
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|January 1, 1995
[Development of a control method for sample distributors]F Durand, B Annic, B Genetet
Annals of Internal Medicine|July 6, 2000
Evidence of hepatitis C virus viremia without detectable antibody to hepatitis C virus in a blood donorF Durand, A Beauplet, P Marcellin
Medicine and Science in Sports and Exercise|May 5, 2000
Evidence for an inadequate hyperventilation inducing arterial hypoxemia at submaximal exercise in all highly trained endurance athletesF Durand, P Mucci, C Préfaut
Gastroenterologie Clinique Et Biologique|July 11, 2008
[Refractory ascites in patients with cirrhosis]R Moreau, F Durand, D Lebrec
Hepatology (Baltimore, Md.)|September 26, 1997
Ketoconazole-induced hepatotoxicityJ Bernuau, F Durand, D Pessayre
Acta Endocrinologica|September 1, 1978
Effect of glucocorticoids on plasma testosterone in menG Schaison, F Durand, I Mowszowicz
Journal of Chromatography|December 18, 1981
A fast and simple high-performance liquid chromatographic assay for aryl hydrocarbon hydroxylaseJ E Tulliez, E F Durand
Gastroenterologie Clinique Et Biologique|March 28, 2008
[Nutritional assessment in cirrhosis]S Buyse, F Durand, F Joly
Gastroenterologie Clinique Et Biologique|October 8, 1998
[Hepatotoxicity of antituberculosis drugs: practical implications for monitoring]F Durand, J Bernuau, D Pessayre
Pageof 22